Page last updated: 2024-08-21

adamantane and tanespimycin

adamantane has been researched along with tanespimycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, DJ; De, S; Melo, JV; Moravcsik, E; van Hensbergen, P	1

Other Studies

1 other study(ies) available for adamantane and tanespimycin

Article	Year
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines. Leukemia, 2007, Volume: 21, Issue:3 Topics: Adamantane; Animals; Antineoplastic Agents; Benzamides; Benzoquinones; Cell Line, Transformed; Cell Line, Tumor; Clone Cells; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, abl; HSP90 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Hydroquinones; Imatinib Mesylate; Lactams, Macrocyclic; Mice; Mutant Proteins; Mutation, Missense; Oxidative Stress; Piperazines; Point Mutation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcr; Pyrimidines; Reactive Oxygen Species; Recombinant Fusion Proteins; Signal Transduction; STAT5 Transcription Factor; Substrate Specificity; Transfection	2007

Article

Year

Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines.

Leukemia, 2007, Volume: 21, Issue:3

Topics: Adamantane; Animals; Antineoplastic Agents; Benzamides; Benzoquinones; Cell Line, Transformed; Cell Line, Tumor; Clone Cells; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, abl; HSP90 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Hydroquinones; Imatinib Mesylate; Lactams, Macrocyclic; Mice; Mutant Proteins; Mutation, Missense; Oxidative Stress; Piperazines; Point Mutation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcr; Pyrimidines; Reactive Oxygen Species; Recombinant Fusion Proteins; Signal Transduction; STAT5 Transcription Factor; Substrate Specificity; Transfection

2007